Intimation Under Regulation 30 & 33 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)
06-Feb-2026 | Source : BSEWe are hrereby submting the financial result for quater ended 31st December 2025 under regulation 33 of SEBI (LODR) Regulation 2015.
Board Meeting Outcome for Intimation Under Regulation 30 & 33 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)
06-Feb-2026 | Source : BSEIn continuation to our earlier communication dated 02™ February 2026 and pursuant to Regulation 30 33 and other applicable regulations read with Schedule Il of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations 2015) as amended from time to time we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. on Friday 06th February 2026 at the registered office of the Company commenced at 03:00 PM and concluded at 04.00 PM transacted inter alia the following businesses: 1. Approved the Unaudited Standalone and Unaudited Consolidated Financial Results for the quarter and nine month ended 31% December 2025 as per the provisions of Regulation 33 of SEBI Listing Regulations 2015 together with the Limited Review Report(s) thereon issued by M/s. Krishan Rakesh & Co Chartered Accountants Statutory Auditors.
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Regulation 29 Of The SEBI Listing Regulations - Intimation Regarding Board Meeting Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company.
02-Feb-2026 | Source : BSEAlchemist Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday 06 February 2026 inter-alia to consider and approve the Unaudited Financial Results of the Company both on Standalone and Consolidated basis for the quarter and nine months ended December 31 2025. In continuation to our letter dated December 26 2025 regarding the closure of Trading Window from January 1 2026 till 48 hours after public announcement of the Unaudited Financial Results for the quarter and nine months ended December 31 2025 we wish to inform you that the Trading Window will remain closed till February 08 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






